Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?
Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that Bicycle Therapeutics hired Rosamond Deegan as president and chief business officer. Previously, she worked at Trevena, where she most recently senior vice president, business development and operations. Before that, she was director of business development at GlaxoSmithKline in the United States.
Gilead Sciences named Kevin Young as chief operating officer;
Gilead Sciences says Paul Carter, executive vice president, commercial operations, is leaving;
Gilead Sciences hired Dr. Martin Silverstein as executive vice president, strategy;
Regulus Therapeutics hired Allison Wey as vice president, investor relations and corporate communications;
Ariad Pharmaceuticals hired Jennifer Herron as executive vice president, chief commercial officer;
Valeant Pharmaceuticals hired Sam Eldessouky as senior vice president and corporate controller;
Valeant Pharmaceuticals says Brian Stolz resigned as senior VP of neurology, dentistry, and genetics;
Orexigen Therapeutics says Dr. Preston Klassen resigned as executive VP, global development;
Orexigen Therapeutics named Peter Flynn as senior VP, head of development, regulatory affairs;
Johnson & Johnson named Michael Sneed as chief communications officer;
Cell Medica hired Alain Pralong as senior vice president, head of manufacturing operations;
Cell Medica hired Stefanos Theoharis as senior VP, head of pipeline strategy and commercial partnering.
About the Author Reprints
